28 March 2024 in JBMR Plus
Genome wide association study (GWAS)-implicated bone mineral density (BMD) signals have been shown to localize in cis-regulatory regions of distal effector genes using 3D genomic methods. Detailed characterization of such genes can reveal novel causal genes for BMD determination. Here, we elected to characterize the “DNM3” locus on chr1q24, where the long non-coding RNA DNM3OS and the embedded microRNA MIR199A2 (miR-199a-5p) are implicated as effector genes contacted by the region harboring variation in linkage disequilibrium with BMD-associated sentinel single nucleotide polymorphism, rs12041600. During osteoblast differentiation of human mesenchymal stem/progenitor cells (hMSC), miR-199a-5p expression was temporally decreased and correlated with the induction of osteoblastic transcription factors RUNX2 and Osterix. Functional relevance of miR-199a-5p downregulation in osteoblastogenesis was investigated by introducing miR-199a-5p mimic into hMSC. Cells overexpressing miR-199a-5p depicted a cobblestone-like morphological change and failed to produce BMP2-dependent extracellular matrix mineralization. Mechanistically, a miR-199a-5p mimic modified hMSC propagated normal SMAD1/5/9 signaling and expressed osteoblastic transcription factors RUNX2 and Osterix but depicted pronounced upregulation of SOX9 and enhanced expression of essential chondrogenic genes ACAN, COMP, and COL10A1. Mineralization defects, morphological changes, and enhanced chondrogenic gene expression associated with miR-199a-5p mimic over-expression were restored with miR-199a-5p inhibitor suggesting specificity of miR-199a-5p in chondrogenic fate specification. The expression of both the DNM3OS and miR-199a-5p temporally increased and correlated with hMSC chondrogenic differentiation. Although miR-199a-5p overexpression failed to further enhance chondrogenesis, blocking miR-199a-5p activity significantly reduced chondrogenic pellet size, extracellular matrix deposition, and chondrogenic gene expression. Taken together, our results indicate that oscillating miR-199a-5p levels dictate hMSC osteoblast or chondrocyte terminal fate. Our study highlights a functional role of miR-199a-5p as a BMD effector gene at the DNM3 BMD GWAS locus, where patients with cis-regulatory genetic variation which increases miR-199a-5p expression could lead to reduced osteoblast activity. Genome wide association study (GWAS) implicated candidate causal variants principally reside in non-coding regulatory regions of the genome and can influence the cis expression of effector genes from relatively large distances. Many of these phenomena are specific to cellular context and can be determined through 3-dimensional genomic approaches. Functional characterization to define the impact of putative candidate effector genes on bone cell differentiation is a necessary first step in functionalizing GWAS discoveries to understand phenotypic variation. We previously implicated miR-199a-5p embedded in the long non-coding RNA DNM3OS as bone mineral density (BMD) effector gene at the DNM3 GWAS locus. The osteochondral fate specification of progenitor cells depended on the expression and activity of miR-199a-5p. Down-regulation of miR-199a-5p was required for terminal osteoblast differentiation while chondrogenic differentiation was severely impaired by its inhibition. miR-199a-5p expression mediated cobblestone-like morphological changes in progenitor cells. Although bone morphogenetic protein-mediated SMAD1/5/9 signaling and expression of downstream osteoblastic transcription factors RUNX2 and Osterix appeared intact in miR-199a-5p expressing cells, miR-199a-5p led to sustained increase in the levels of chondrogenic transcription factor SOX9 and downstream chondrocyte marker genes. Given the importance of miR-199a-5p in dual fate specification of progenitor cells, patients with cis-regulatory variants that increase 199a-5p expression may have reduced osteoblast activity that leads to osteopenia/osteoporosis.